News
Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...
A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...
An elderly American man has become completely blind after he was prescribed to take Ozempic to manage his type 2 diabetes.
This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...
If found to be lacking adequate compliance systems, Moderna could ultimately be suspended or expelled from the Association of ...
Health and Me on MSN19h
US Man Became Blind After Consuming Ozempic: Do Weight Loss Drugs Cause Blindness?Todd Engel, a Maryland man, is suing Ozempic maker Novo Nordisk after allegedly going blind due to the drug, raising concerns ...
Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback